A randomized trial of ImpACT+, a coping intervention to improve clinical and mental health outcomes among HIV-infected women with sexual trauma in South Africa

ImpACT 的一项随机试验,这是一种应对干预措施,旨在改善南非患有性创伤的艾滋病毒感染妇女的临床和心理健康结果

基本信息

  • 批准号:
    10001638
  • 负责人:
  • 金额:
    $ 60.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-23 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Addressing sexual trauma in the context of HIV care is essential to improve clinical outcomes and mental health among women in South Africa. Women represent nearly two-thirds of the South African HIV epidemic, and they report disproportionately high rates of sexual trauma, which negatively impacts their mental health and may lead to avoidant coping behaviors. The psychological sequaelae of trauma can adversely impact retention in HIV care and adherence to antiretroviral therapy (ART), which may in turn reduce viral suppression and increase the risk of HIV transmission to others. HIV care engagement may be particularly challenging in South Africa, where women face dual epidemics of HIV and sexual violence, with limited access to mental health treatment. In this setting, interventions that address barriers to effective HIV care engagement and improve health outcomes across the care continuum are urgently needed. The primary objective of this study is to evaluate the effectiveness of ImpACT+ (Improving AIDS Care after Trauma+), an individual-level intervention based on theories of stress and coping, on clinical outcomes among HIV-infected women with sexual trauma. Secondary objectives include determining whether reductions in traumatic stress and avoidant coping mediate intervention effects on clinical outcomes, and assessing potential for scalability and full-scale implementation. ImpACT+ was developed and culturally adapted to the South African context, targeting women who are newly initiating ART to make use of a window of opportunity in HIV care and maximize impact on care engagement. The proposed five-year study seeks to rigorously evaluate ImpACT+, using a hybrid effectiveness-implementation design (Hybrid Type I), with three specific aims: (1) evaluate the effectiveness of ImpACT+ on viral suppression, ART adherence, and HIV care engagement; (2) assess the degree to which reductions in PTSD symptoms and avoidant coping mediate intervention effects; and (3) explore potential for scalability and full-scale implementation. The trial will enroll 350 women who have newly initiated ART and have a history of sexual trauma and elevated traumatic stress. Participants will be randomized to the ImpACT+ intervention condition (six weekly sessions, with six maintenance check-ins over the 12-month follow-up period) or the control condition (three weekly sessions of Problem Solving Therapy (PST)). All participants will complete a baseline assessment at enrollment (within four months of initiating ART), with additional behavioral assessments and viral load testing at 4-month, 8-month, and 12-month follow-up. ART adherence will also be assessed using dried blood spot (DBS) biomarkers, and care engagement data will be extracted from medical records at the end of the study period. This study is one of the first full-scale trials of a trauma-informed intervention on clinical outcomes for HIV-infected women. If effective, ImpACT+ will fill a critical void in evidence-based trauma interventions in this setting and combat the drop-off across the HIV continuum of care in South Africa, as well as inform such approaches in the U.S. and globally.
项目摘要 在艾滋病毒护理的背景下处理性创伤对于改善临床结果和心理健康至关重要。 南非妇女的健康状况。妇女占南非艾滋病毒流行病的近三分之二, 他们报告说,性创伤的发生率不成比例地高,这对他们的心理健康产生了负面影响。 并可能导致回避型应对行为。创伤的心理后遗症会对 继续接受艾滋病毒护理和坚持抗逆转录病毒治疗(ART),这反过来可能会减少病毒抑制 并增加艾滋病毒传播给他人的风险。艾滋病毒护理参与可能特别具有挑战性, 南非,妇女面临艾滋病毒和性暴力的双重流行,获得精神卫生服务的机会有限, 健康治疗。在这种情况下,解决有效艾滋病毒护理参与障碍的干预措施, 迫切需要改善整个护理连续体的健康结果。本研究的主要目的是 为了评估ImpACT+(改善创伤后艾滋病护理)的有效性, 基于压力和应对理论的干预对感染艾滋病毒的女性的临床结果 性创伤第二个目标包括确定是否减少创伤压力和回避 应对中介干预对临床结果的影响,并评估可扩展性和全尺度的潜力 实施.制定了ImpACT+,并在文化上适应南非的情况, 新开始抗逆转录病毒疗法的妇女利用艾滋病毒护理的机会之窗,并最大限度地发挥影响 关于关怀参与拟议的五年期研究旨在使用混合方法严格评估ImpACT+。 有效性-实施设计(混合型I),有三个具体目标:(1)评估 ImpACT+对病毒抑制、ART依从性和HIV护理参与的影响;(2)评估 减少PTSD症状和回避应对介导的干预效果;(3)探索潜在的 可扩展性和全面实施。该试验将招募350名新开始ART的女性, 有过性创伤和创伤压力过大的病史受试者将被随机分配至ImpACT+ 干预条件(每周6次,在12个月随访期间进行6次维护检查 期)或控制条件(每周三次的问题解决疗法(PST))。所有参与者将 在入组时完成基线评估(在开始ART的四个月内), 在4个月、8个月和12个月随访时进行评估和病毒载量检测。抗逆转录病毒疗法也将是 使用干血斑(DBS)生物标志物进行评估,护理参与数据将从医疗数据库中提取。 研究结束时的记录。这项研究是第一个全面的试验之一, 对艾滋病毒感染妇女的临床结果进行干预。如果有效,ImpACT+将填补 在这种情况下,以证据为基础的创伤干预措施, 在南非,以及通知在美国和全球的这种方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATHLEEN J SIKKEMA其他文献

KATHLEEN J SIKKEMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATHLEEN J SIKKEMA', 18)}}的其他基金

A randomized trial of ImpACT+, a coping intervention to improve clinical and mental health outcomes among HIV-infected women with sexual trauma in South Africa
ImpACT 的一项随机试验,这是一种应对干预措施,旨在改善南非患有性创伤的艾滋病毒感染妇女的临床和心理健康结果
  • 批准号:
    10153891
  • 财政年份:
    2019
  • 资助金额:
    $ 60.93万
  • 项目类别:
A randomized trial of ImpACT+, a coping intervention to improve clinical and mental health outcomes among HIV-infected women with sexual trauma in South Africa
ImpACT 的一项随机试验,这是一种应对干预措施,旨在改善南非患有性创伤的艾滋病毒感染妇女的临床和心理健康结果
  • 批准号:
    10409645
  • 财政年份:
    2019
  • 资助金额:
    $ 60.93万
  • 项目类别:
A randomized trial of ImpACT+, a coping intervention to improve clinical and mental health outcomes among HIV-infected women with sexual trauma in South Africa
ImpACT 的一项随机试验,这是一种应对干预措施,旨在改善南非患有性创伤的艾滋病毒感染妇女的临床和心理健康结果
  • 批准号:
    10615902
  • 财政年份:
    2019
  • 资助金额:
    $ 60.93万
  • 项目类别:
Improving the health of South African women with traumatic stress in HIV care
改善在艾滋病毒护理中遭受创伤性压力的南非妇女的健康
  • 批准号:
    8729135
  • 财政年份:
    2014
  • 资助金额:
    $ 60.93万
  • 项目类别:
Improving the health of South African women with traumatic stress in HIV care
改善在艾滋病毒护理中遭受创伤性压力的南非妇女的健康
  • 批准号:
    9063619
  • 财政年份:
    2014
  • 资助金额:
    $ 60.93万
  • 项目类别:
Improving the health of South African women with traumatic stress in HIV care
改善艾滋病毒护理中遭受创伤性压力的南非妇女的健康
  • 批准号:
    8866300
  • 财政年份:
    2014
  • 资助金额:
    $ 60.93万
  • 项目类别:
Social and Behavioral Sciences
社会与行为科学
  • 批准号:
    7930107
  • 财政年份:
    2010
  • 资助金额:
    $ 60.93万
  • 项目类别:
Brief Care-based HIV Prevention for Newly Diagnosed Men
针对新诊断男性的简要护理型艾滋病毒预防
  • 批准号:
    7545669
  • 财政年份:
    2009
  • 资助金额:
    $ 60.93万
  • 项目类别:
Brief Care-based HIV Prevention for Newly Diagnosed Men
针对新诊断男性的简要护理型艾滋病毒预防
  • 批准号:
    7862343
  • 财政年份:
    2009
  • 资助金额:
    $ 60.93万
  • 项目类别:
HIV Prevention Among SMI in Transitional Housing
过渡性住房中的 SMI 的艾滋病毒预防
  • 批准号:
    6315881
  • 财政年份:
    2001
  • 资助金额:
    $ 60.93万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 60.93万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 60.93万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 60.93万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 60.93万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 60.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了